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Abstract
Background: Cocaine- and amphetamine-regulated transcript (CART) has been demonstrated to play a role in regulating
the rewarding and reinforcing effects of various drugs of abuse. A recent study demonstrated that i.c.v. administration of
CART negatively modulates reinstatement of alcohol seeking, however, the site(s) of action remains unclear. We
investigated the paraventricular thalamus (PVT) as a potential site of relapse-relevant CART signaling, as this region is known
to receive dense innervation from CART-containing hypothalamic cells and to project to a number of regions known to be
involved in mediating reinstatement, including the nucleus accumbens (NAC), medial prefrontal cortex (mPFC) and
basolateral amygdala (BLA).
Methodology/Principal Findings: Male rats were trained to self-administer cocaine before being extinguished to a set
criterion. One day following extinction, animals received intra-PVT infusions of saline, tetrodotoxin (TTX; 2.5 ng), CART
(0.625 mg or 2.5 mg) or no injection, followed by a cocaine prime (10 mg/kg, i.p.). Animals were then tested under extinction
conditions for one hour. Treatment with either TTX or CART resulted in a significant attenuation of drug-seeking behaviour
following cocaine-prime, with the 2.5 mg dose of CART having the greatest effect. This effect was specific to the PVT region,
as misplaced injections of both TTX and CART resulted in responding that was identical to controls.
Conclusions/Significance: We show for the first time that CART signaling within the PVT acts to inhibit drug-primed
reinstatement of cocaine seeking behaviour, presumably by negatively modulating PVT efferents that are important for
drug seeking, including the NAC, mPFC and BLA. In this way, we identify a possible target for future pharmacological
interventions designed to suppress drug seeking.
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Introduction
Cocaine- and amphetamine-regulated transcript (CART) is a
neuropeptide that was originally identified in the striatum of
animals following acute psychostimulant exposure [1]. Subsequent
studies have identified that CART is expressed in a number of
regions known to be involved in reward and reinforcement,
including the ventral tegmental area (VTA), nucleus accumbens
(NAC), amygdala and hypothalamus [2,3]. Early studies firmly
established a role for CART in appetite control, with central
administration of CART found to dose-dependently suppress
feeding behaviour [4]. More recently however, there has been a
renewed interest in the role that CART might play in modulating
the rewarding and reinforcing effects of drugs of abuse, and in
particular, psychostimulants such as cocaine and amphetamine
[5–10].
The effects of CART on the reinforcing and locomotor-
activating properties of psychostimulants are complex and appear
to be both brain region- and dose- dependent. For example,
administration of the active CART55-102 peptide into the VTA
results in a cocaine-like increase in locomotor activity and
produces a conditioned place preference (CPP) similar to that
induced by cocaine or amphetamine [11], indicating that CART
signaling in this region is reinforcing. However, administration of
CART55-102 into the NAC or the ventral pallidum (VP)
significantly attenuates the locomotor effects of acute cocaine
and amphetamine administration [12–14], and prevents the
expression of conditioned hyperlocomotion in a cocaine-paired
environment [15]. Together, these data suggest that CART
signaling within the NAC and VP works to negatively regulate the
effects of psychostimulants. Interestingly, when administered into
the basolateral amygdala (BLA), lower doses of CART appear to
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12980be rewarding, whilst higher doses are aversive [6]. Taken together,
these findings strongly implicate CART as a regulator of the
reinforcing and rewarding effects of psychostimulants, however the
effects appear to be highly regional and dose specific.
A recent study suggests that CART may also be involved in
mediating the reinstatement of extinguished drug seeking, as
intracerebroventricular (i.c.v.) administration of CART was found
to prevent context-induced reinstatement of alcohol seeking in rats
[16]. Importantly though, it remains unclear as to whether CART
mediates reinstatement in animals that have a significant history of
psychostimulant exposure. Further, it is important that the site(s) at
which CART exerts its inhibitory effects in a reinstatement model
be determined.
A region of particular interest with regards to the integration of
CART peptide activity is the paraventricular thalamus (PVT). The
PVT is a part of the midline and intralaminar thalamic group and
is known to receive dense innervation from CART-containing
neurons in the lateral hypothalamus [17–19]. Importantly, the
PVT is known to project to a number of regions implicated in the
reinstatement of drug seeking, including the NAC, medial PFC
(mPFC) and BLA [18,20–23] and therefore represents a possible
site through which hypothalamic CART activity may be relayed to
relapse-relevant regions. Consistent with this idea, presentation of
stimuli previously associated with alcohol availability increases the
activation of neurons within the PVT and these neurons are
closely apposed to CART terminal fields [10]. Further, excitotoxic
lesions of the PVT have been shown to prevent context-induced
reinstatement of alcohol seeking [24]. At present however, it is
unclear whether the role of the PVT extends to other forms of
reinstatement (e.g. drug-primed reinstatement) and to other drugs
of abuse (e.g. psychostimulants). Further, it is unclear whether any
role that the PVT may play in reinstatement is directly related to
CART signaling in this region.
Therefore, here we examined the role that the PVT plays in
modulating drug-primed reinstatement of cocaine seeking by
functionally inactivating the PVT with the sodium channel blocker
tetrodotoxin (TTX) prior to reinstatement testing. We also
investigated the effects of intra-PVT infusions of the active
CART55-102 neuropeptide on reinstatement behaviour. We found
that treatment with either TTX or CART produced a significant
attenuation of drug-seeking behaviour following cocaine prime.
Results
Guide Cannulae Placement
As shown in Figure 1, guide cannulae from the majority of
animals were localized to the PVT. Four TTX-treated animals
were found to have guide cannulae that were misplaced; two were
directed at the third ventricle, another at the central medial
thalamic nucleus (CM), and the other at the boundary of the
intermediodorsal thalamic nucleus (IMD) and the CM. The guide
cannulae from one animal treated with 0.625 mg CART was
directed at the stria medullaris of the thalamus, whilst one animal
treated with 2.5 mg CART had its guide cannulae directed at the
lateral boundary of the IMD and the CM.
Self-Administration Training and Extinction
Rats developed stable responding (610% over 3 sessions) for
cocaine within 8 days of training (61.04 SEM). Over the last three
days of cocaine self-administration training, the mean number of
cocaine infusions per session across all animals was 29.32 (61.43
SEM), which equated to approximately 19 mg/kg of cocaine per
session. Importantly, levels of cocaine consumption did not differ
across the four treatment groups. During cocaine-self administra-
tion, animals significantly favoured the active cocaine-paired lever
as compared to the inactive lever (F1,27=130.84, p,.001) and this
preference did not differ between the treatment groups
(F3,27=1.47, p=.24). Animals met the extinction criteria after
an average of 20.65 (61.87 SEM) days and the number of days
taken to reach the extinction criterion was indistinguishable across
all groups (F3,30=.95, p=.43).
Reinstatement Testing
After reaching the extinction criterion, all animals were
subjected to a cocaine prime. Animals that received intra-PVT
saline-injections prior to cocaine-priming injections displayed an
identical reinstatement of responding on the active lever to animals
that were prepared with PVT-guide cannulae but received no
injection (F1,11=.60, p=.46). We therefore combined these two
groups to form a single ‘Control’ group (n=12). ANOVA revealed
a significant main effect of ‘session’ (F1,27=30.24, p,.001),
indicating that the cocaine-prime brought about an overall
increase in responding from extinction levels. A significant ‘session’
x ‘treatment’ interaction was also observed (F3, 27=8.26, p,.001)
suggesting differences in the extent to which the treatments
affected cocaine prime-induced reinstatement of responding.
Planned, separate post-hoc analyses revealed that TTX-treated
animals displayed on average a lower level of responding on the
active lever compared to controls (p=.05). Similarly, animals
treated with either 0.625 mg CART55-102 and 2.5 mg CART55-
102 exhibited significantly reduced reinstatement responding
compared to controls (ps,.01), with the 2.5 mg CART dose
having the greatest effect (see Figure 2A). Importantly, changes in
lever pressing behaviour by all treatments was limited to the active
lever with neither a significant main effect (F1,27=1.97, p=.17)
nor a significant interaction (F3,27=1.47, p=.25) observed for left
(inactive) lever responses during the test phase (see Figure 2C).
We also assessed differences in responding on the active lever at
ten-minute intervals across the one-hour reinstatement session (see
Figure 2B). Repeated measures ANOVA revealed a significant
‘time’ x ‘treatment’ interaction (F675.63, 137.70=4.91, p,.01,
Huynh-Feldt correction). Planned post-hoc t-test comparisons
revealed that the control group exhibited significantly greater
levels of responding in the first ten minutes of reinstatement testing
than the 2.5 mg CART group (p,.05, adjusted for multiple
comparisons), but not the TTX- or 0.625 mg CART- treated
groups. At all other time points, the control group exhibited
significantly greater levels of responding than all other treatment
groups (ps,.05, adjusted for multiple comparisons).
We also examined the responding of animals that had misplaced
guide cannuale to determine the specificity of the observed effects to
the PVT. The four animals that received misplaced TTX injections
(M=49.25, SE=27.86) did not differ in their active lever responses
to the control group (M=64, SE=8.69; F1,15=0.47, p=.50), but
did respond on average at a higher rate to animals that received
PVT-directed TTX (M=34.57, SE=6.25). Similarly, the two
animals that received misplaced CART injections (M=64.5,
SE=22.5) responded on the active lever at a level almost identical
to controls, but higher than the PVT-directed 0.625 mg CART
(M=19, SE=6.47) and 2.5 mg CART (M=14.17, SE=4.73)
groups. As such, the effect of both TTX and CART treatment
was most pronounced when injected into the PVT.
Discussion
The purpose of the present study was two-fold. Firstly, we aimed
to investigate whether the role of the PVT in modulating
reinstatement to cue and context-induced alcohol seeking
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TTX administration to functionally inactivate the PVT prior to
cocaine-primed reinstatement testing. We report that TTX-
treated animals exhibited significantly attenuated drug-seeking
behaviour following drug prime, showing for the first time that the
PVT plays an important role in mediating drug primed ‘relapse’ of
cocaine-seeking behaviour. Our second aim was to determine
whether CART signaling within the PVT might regulate drug-
seeking behaviour, as we have previously shown CART-contain-
ing terminals within the PVT to be closely apposed to drug-cue
activated PVT neurons [10]. Further, PVT cells project to a
number of relapse-relevant brain regions including the NAC,
mPFC and BLA [18–23]. To achieve these aims, animals were
treated with either 0.625 mg or 2.5 mg of the CART55-102
peptide, based on previous studies that examined the role of
CART in drug-motivated behaviours [6,11,13,15,16]. CART
produced a significant attenuation of drug-seeking following drug-
prime, with the 2.5 mg dose having the greatest effect. These
findings build upon previous reports that i.c.v. CART inhibits
reinstatement [16] by identifying a specific site at which CART
acts to modulate relapse-like behaviour.
It is noteworthy that PVT-directed treatment did not alter
responding on the inactive lever, suggesting that the effects we
observed were specific to drug-seeking rather than a generalized
reduction in arousal or locomotor activity as a result of CART or
TTX infusion. Whilst it is possible that low levels of overall
responding on the inactive lever may have masked a non-specific
effect of CART or TTX, several pieces of evidence indicate that
this is highly unlikely. Firstly, previous work studying the effects of
ibotenic acid lesions of the PVT on renewal of beer seeking
reported no alterations in inactive nose-poke responding [24].
Presumably, these lesions also disrupted CART signaling onto
PVT cells as well as the actions of other inputs into this site.
Secondly, i.c.v. [16] and intra-accumbal infusions [15] of CART
resulted in a specific reduction of drug-related locomotor activity,
and i.c.v. CART injections do not alter spontaneous locomotor
activity [4]. It is also important to note that CART has been
reported to produce some postural changes and motor tremors.
For example, i.c.v. infusion of 1 mgo r2mg of CART produced a
modest movement-associated tremor, however this did not impair
the ability of the animals to engage in reward-seeking behaviour,
nor did it significantly alter locomotor activity [4]. Motor tremors
Figure 1. Location of microinfusion injector tips. The majority of injections were made directly into the PVT region. Four TTX-treated animals
and two CART-treated animals had injections that fell beyond the PVT boundary, and the responding of these animals was assessed to determine the
specificity of the observed effects to the PVT. Numbers represent the approximate rostrocaudal distance from bregma. Figures adapted from Paxinos
and Watson [44]. Symbols represent different groups;N: saline; #: TTX; e: 0.625 mg CART; %: 2.5 mg CART; X: misplaced TTX; *: misplaced 0.625 mg
CART injections; #: misplaced 2.5 mg CART injections. CM: central medial thalamic nucleus; D3V: dorsal third ventricle; IMD: intermediodorsal thalamic
nucleus; MDC: mediodorsal thalamic nucleus, central part; MDM: mediodorsal thalamic nucleus, medial part; PVA: Paraventricular thalamic nucleus,
anterior part; PVT: Paraventricular thalamic nucleus; PVP: Paraventricular thalamic nucleus, posterior part.
doi:10.1371/journal.pone.0012980.g001
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CART, but not a 1 mg dose [11]. Importantly, close observation of
our animals revealed no evidence of motor effects at the relatively
low doses of CART used in our study.
It should also be noted that a dorsal approach to the PVT for
the placement of guide cannulae was employed in our study.
Whilst this approach, as compared to an angled approach, may
have marginally increased the possibility of the injectate spreading
dorsally into the D3V, we are confident that the observed effects
were specific to the PVT region. This conclusion is based on the
responding seen from animals with misplaced injections of TTX
directed at the D3V that resulted in responding that was
indistinguishable from control animals. Similarly, animals that
received TTX and CART injections that were directed at
thalamic structures surrounding the PVT and, indeed one case
that was adjacent to the D3V, also exhibited responding that was
identical to controls, again indicating PVT-specific effects.
Importantly, CART and TTX infusions were made at various
rostro-caudal levels of the PVT, and responding within each
treatment group was consistent at all injection sites. This is
consistent with anatomical tracing studies that suggest that the
number of projections to relapse relevant brain regions is relatively
consistent along the entire rostro-caudal length of the PVT [18].
The PVT is known to respond to noxious stimulation, and
inputs from tactile and nociceptive pathways have been hypothe-
sised to be integrated within intralaminar and midline thalamic
nuclei [25,26]. Further, hypothalamic-pituitary-adrenal (HPA)
axis [27] and central amygdala [28] responses to stress are altered
by functional manipulations of the PVT. It has been inferred from
these data that the PVT plays an important role in arousal and
attentional control. The present findings build upon this literature
and strongly support an emerging body of evidence that suggests
that the PVT also plays a critical role in reward-related processing
[29]. For example, PVT lesions blocked the conditioned
locomotor response to a cocaine-paired environment in a
sensitization experiment [30], whilst PVT activation has been
shown to be associated with increased locomotor responses
entrained to regulated feeding schedules [31]. Particularly
pertinent to the present study, the PVT has recently been
implicated in modulating the reinstatement of alcohol seeking. For
example, presentation of cues previously associated with alcohol
availability increased c-fos expression within the PVT [10], whilst
ibotenic acid lesions of the PVT prevented context-induced
reinstatement of alcohol seeking [24]. Together, these data
indicate a role for the PVT in reward-seeking behavior that we
demonstrate here also includes reinstatement of drug-seeking
behaviour precipitated by a cocaine prime.
It has recently been suggested that the PVT modulates reward-
related behaviour by acting to integrate and relay hypothalamic
activity to reward-relevant regions, including the NAC and
perhaps the mPFC [29]. Indeed, anatomical tracing studies have
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Figure 2. Microinfusion of TTX or CART into the PVT attenuates
cocaine-primed reinstatement. All animals were tested following a
cocaine prime (10 mg/kg, i.p.) preceded by a PVT-directed microinfu-
sion of either saline, 2.5 ng TTX, 0.625 mg CART55-102 or 2.5 mg
CART55-102 (n=6–7). A group of animals served as no-injection
controls, and were grouped with saline-treated animals to form a
‘control’ group (CONT). Treatment with TTX or CART produced a
significant attenuation of active lever responding following cocaine
prime, as compared to controls {: p=.05, {{: p,.01, significantly
different to controls (A). Control animals exhibited a significantly higher
level of active lever responding than 2.5 mg CART-treated animals in the
first ten minutes of reinstatement testing. At all other time points,
control animals exhibited significantly higher levels of responding than
TTX- and both CART-treatment groups. {: Control group significantly
different to TTX-treatment group; #: Control group significantly
different to 0.625 mg CART-treatment group; * : Control group
significantly different to 2.5 mg CART-treatment group, all ps,.05 (B).
Importantly, TTX and CART treatment did not affect responding on the
inactive lever, indicating that the observed effects were specific to
drug-seeking behaviour rather than an overall reduction in arousal and/
or locomotion (C). SA: Average number of active lever presses over last
three days of self-administration training period. EXT: Average number
of active lever presses over last three days of extinction training. Error
bars represent (+ S.E.M.).
doi:10.1371/journal.pone.0012980.g002
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hypothalamus [18,19,32,33] and in turn sends glutamatergic
projections to the NAC, mPFC and BLA [20–23]. Further,
stimulation of the PVT has been shown to modulate neuronal
excitability in both the NAC and PFC [23,34,35]. Interestingly, a
significant percentage of PVT neurons send collateral (i.e.
branched) projections to both the NAC and mPFC, suggesting
that the PVT is anatomically positioned to simultaneously
influence both of these drug-relevant regions [20,22]. Further-
more, CART-positive terminal fibres in the PVT are closely
apposed to neurons that project directly to the NAC shell [19].
Taken together with the data presented here, we propose that
CART signaling within the PVT acts to inhibit drug-primed
reinstatement by modulating the activity of PVT-efferents,
including to the NAC and/or mPFC. Indeed, electrophysiological
studies indicate that CART can produce inhibitory post-synaptic
effects when applied to brain slices [36].
Consistent with this suggestion, anatomical studies show that
glutamatergic efferents from the PVT are closely associated with
dopamine immunoreactive terminals in the NAC shell, and this
relationship may potentiate NAC activity [37]. Indeed, stimula-
tion of the PVT increases dopamine efflux within the shell of the
NAC [35]. The NAC has been extensively demonstrated to be
critically involved in the reinstatement of drug-seeking behaviour.
For example, NAC shell inactivation suppresses reinstatement of
drug-seeking elicited by contextual cues [38] and NAC shell
neurons show increased levels of activation after presentation of
drug-paired discriminative stimuli measured using Fos [39] or
single unit recordings [40]. In addition, dopamine antagonist
injections aimed at the NAC shell block the reinstatement of
cocaine seeking induced by a drug prime [41]. Taken together,
these data indicate that CART might act to suppress drug-primed
reinstatement by preventing PVT-glutamate efferents modulating
the responsivity of NAC neurons to cocaine-induced dopamine
release.
In summary, we demonstrate that the PVT plays an integral
role in modulating drug-primed reinstatement of cocaine seeking
and that CART signaling within this region negatively regulates
relapse-like behaviour. Whilst not directly addressed here,
CART signaling in the PVT may act to negatively modulate
dopamine release within the NAC and other regions known to
be involved in reinstatement. As such, CART signaling within
the PVT may represent a potential target for pharmacological
interventions designed to suppress drug-seeking behaviour. It
will be for future studies to determine if CART signaling also
suppresses drug seeking evoked by cues linked to drug taking
and stress. Presumably however, a full evaluation of the
potential role of CART as a therapeutic treatment target awaits
the identification of the receptor system through which this
peptide acts.
Materials and Methods
Ethics Statement
All procedures performed were approved by the University of
Newcastle Animal Care and Ethics Committee (approval number
1068), and were carried out in accordance with the New South
Wales Animal Research Act.
Animals
Male Sprague-Dawley rats (Central Animal House, University
of Newcastle, NSW, AUS; weighing 200–250 g upon arrival) were
housed two per cage on a reverse 12-hour light/dark cycle (lights
off at 7:00 am) with ad libitum access to food and water.
Drugs
Rat CART55-102 (Phoenix Pharmaceuticals, CA, USA) and
TTX (Alomone, Israel) were dissolved in sterile saline and stored
at 4uC until use. Both doses of CART55-102, TTX, and saline
were microinjected at volumes of 0.25 ml.
Surgery
Catheterisation. Prior to surgery, rats were injected
intramuscularly with 0.3 mL of a broad-spectrum antibiotic
(150 mg/mL procaine penicillin, 112.5 mg/mL benzathine
penicillin; Norbrook Laboratories, UK) and subcutaneously with
0.2 mL of a 50 mg/mL solution of carprofen (Norbrook
Laboratories, UK). Rats (250–300 g) were anesthetized with
isofluorane (1–3% with a flow rate of 2 L/min) and, using
aseptic procedures, a Silastic catheter was surgically implanted
into the right jugular vein as described in detail previously [42].
Post-surgery, jugular catheter lines were flushed with 0.3 mL of
50 mg/mL cephazolin (Mayne Pharma, Australia). To ensure
catheter patency throughout the course of the experiment,
catheters were flushed daily with 0.2 mL of 50 unit heparinised
saline.
PVT-Directed Guide Cannulae. Prior to surgery, animals
were treated with procaine penicillin and carprofen as above.
Animals were anesthetized with isofluorane before being placed in
a sterotaxic frame (Stoelting, IL, USA). Craniotomies were made
into the skull to facilitate the insertion of four stainless steel
jeweller’s screws (Mann Optics, QLD, AUS), whilst a fifth
craniotomy was made to allow the insertion of a stainless steel
guide cannula (26 guage, Small Parts, FL, USA) to the level of the
PVT (22.6 mm AP relative to bregma, 24.6 mm DV relative to
skull surface). Guide cannulae were secured to the four screws with
dental cement (Henry Schein, AUS). Cannulae were kept clear by
using stainless steel stylets (33 guage, Small Parts, FL, USA) of
identical length to the guides.
Behavioural Training
Behavioural procedures were conducted in standard operant
conditioning chambers located inside sound-attenuating, ventilat-
ed cubicles (Med Associates, VT, USA). Chambers were equipped
with two retractable levers (6 cm above the floor), white cue lights
(one above each lever), two speakers to deliver auditory stimuli and
a house light located at the top of the chamber wall opposing the
levers. A syringe pump (5 rpm motor, Med Associates, VT, USA)
located on the outside of the sound-attenuating cubicle delivered
the IV cocaine and saline vehicle solutions. Data acquisition and
behavioural testing equipment were controlled by a Windows-
based PC, using MED-PC IV (Med Associates, VT, USA).
Seven days after surgery, rats were trained to self-administer
cocaine hydrochloride (Johnson Matthey, Edinburgh, UK;
dissolved in sterile physiological saline 2.5 mg/mL) intravenously
in three-hour sessions conducted daily for 5 days a week.
Responding on the active (right) lever resulted in a 4 second
infusion of cocaine (0.1 mL) via the intravenous catheter and
activation of a white cue light above the active lever that remained
illuminated for 20 seconds signaling a time out period. The
inactive (left) lever was not extended during the initial training
sessions. Training was continued until stable responding for
cocaine was achieved (610% rewarded responses over 3 sessions)
at which time animals were subjected to eight two-hour sessions
whereby both the active (right) and inactive (left) levers were
presented. In these sessions, responding on the active lever had
similar consequences as in the initial training phase, whilst
responding on the inactive lever was recorded but had no
scheduled consequences.
CART Modulates Reinstatement
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implanted with PVT-directed guide cannulae and were allowed
one week for recovery. Lever responding was then extinguished by
again presenting both the active and inactive levers, but with IV
infusions withheld. Extinction trials continued until a criterion of
#10 responses per session on the active lever over three
consecutive days was achieved.
Reinstatement Testing
Over the final three to five days of extinction training, animals
were gently restrained whilst their stylet was removed and
replaced, in order to condition animals to the testing procedure.
One day following the final extinction session, animals were again
restrained whilst their stylet was removed and placed in 70%
ethanol. Animals then received a microinfusion of either saline
(n=6), 2.5 ng TTX (n=11), 0.625 mg CART (n=7) or 2.5 mg
CART (n=7). A group of six animals were implanted with guide
cannulae into the PVT but were not subjected to intra-PVT
injections and served to control for the effect of intra-PVT drug
infusion on cocaine prime-induced responding. Based on previous
studies the selected dose of TTX was expected to inactivate tissue
within a ,0.35–0.4 mm radius from the site of injection [43] and
therefore have minimal effect on structures surrounding the PVT.
Further, the doses of CART were selected based on previous
reports that these doses are sufficient to modulate the reinforcing
effects of cocaine [13,15]. All microinjections were made through
an injector cannulae (30 guage, Small Parts, FL, USA), which
protruded 1.3 mm below the tip of the guide cannula into the
PVT region. Infusions were delivered using a Hamilton microsy-
ringe mounted on a motorised pump (Stoelting, IL, USA) at a rate
of 2 ml/min. The injector remained in the guide cannulae for a
further minute following administration in order to allow adequate
diffusion of the injectate into the PVT. Animals were then
administered a cocaine drug-prime (10 mg/kg, i.p.) and placed
into the operant chamber. Testing for reinstatement of responding
began five minutes later under extinction conditions for one hour.
Two hours following commencement of testing, animals were
deeply anaesthetized with sodium pentobarbital (200 mg/kg IP)
and transcardially perfused with 150 mLs of PBS (pH 7.4)
followed by 500 mLs of 4% paraformaldehyde (pH 9.5) to allow
for verification of injector sites.
Data Analysis
Separate one-factor ANOVAs were used to compare the
experimental and control groups in terms of number of training
days, overall cocaine intake, time taken to reach extinction, and
responding on both the active and inactive levers over the last
three days of extinction. Lever preference during training was
assessed using a 2 ‘Lever’ (active, inactive) 64 ‘Treatment’
(Control, TTX, 0.625 mg CART, 2.5 mg CART) mixed-model
ANOVA, whilst reinstatement of responding on both the active
and inactive levers was analysed using a 2 ‘Session’ (extinction,
reinstatement) 64 ‘Treatment’ (Control, TTX, 0.625 mg CART,
2.5 mg CART) mixed-model ANOVA. Where significant interac-
tions were observed, planned Tukey post-hoc tests were used to
assess differences between treatment groups. Differences in active
lever responding at various timepoints across the one hour
reinstatement session was assessed using a 4 ‘Treatment’ (Control,
TTX, 0.625 mg CART, 2.5 mg CART) X 6 ‘Time’ (10 min,
20 min, 30 min, 40 min, 50 min, 60 min) repeated measures
ANOVA. Where significant interactions were observed, planned t-
test analyses were used to compare treatment groups and
Bonferroni a corrections were made to control for family-wise
error. An alpha level of .05 was used for all statistical tests.
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